SEC Form 4 · accession 0000792977-19-000052
AMAG PHARMACEUTICALS INC. · AMAG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph Vittiglio
Officer — EVP, General Counsel
Period of report
Mar 7, 2019
Accepted (ET)
Mar 11, 2019 · 4:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000792977
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 7, 2019 | S | 1,425 | $14.01 | D | 78,955 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reported transaction on this Form 4 was automatically effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person on September 11, 2018 in order to cover incremental taxes on the vesting of previous restricted stock unit grants.